Taken together, these findings highlight a unifying mechanism across multiple tumor types, where Dectin-1 signaling fosters an immunosuppressive TME by driving tolerogenic macrophage/MDSC polarization, promoting PGE2 and IL-1β production, and increasing checkpoint expression, all of which converge on dampening T cells cytotoxicity. The gene discussed is IL1B; the disease is neoplasm.